Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 159 citing articles:

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Ugo Testa, Elvira Pelosi, Arthur E. Frankel
Biomarker Research (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 230
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
Arthur E. Frankel, Jung Hee Woo, Chul Ahn, et al.
Blood (2014) Vol. 124, Iss. 3, pp. 385-392
Open Access | Times Cited: 215
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
Abraham S. Kanate, Navneet S. Majhail, Bipin N. Savani, et al.
Biology of Blood and Marrow Transplantation (2020) Vol. 26, Iss. 7, pp. 1247-1256
Open Access | Times Cited: 209
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches
Livio Pagano, Caterina Giovanna Valentini, Sara Grammatico, et al.
British Journal of Haematology (2016) Vol. 174, Iss. 2, pp. 188-202
Open Access | Times Cited: 177
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients
Fanny Julia, Tony Petrella, M. Beylot‐Barry, et al.
British Journal of Dermatology (2013) Vol. 169, Iss. 3, pp. 579-586
Closed Access | Times Cited: 173
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
Juliane Menezes, Francesco Acquadro, Michele S. Wiseman, et al.
Leukemia (2013) Vol. 28, Iss. 4, pp. 823-829
Open Access | Times Cited: 155
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli, Zhiying Esther Hou, Priscilla N. Kelly, et al.
Cancer Cell (2016) Vol. 30, Iss. 5, pp. 764-778
Open Access | Times Cited: 143
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
Khaled Alayed, Keyur P. Patel, Sergej Konoplev, et al.
American Journal of Hematology (2013) Vol. 88, Iss. 12, pp. 1055-1061
Open Access | Times Cited: 133
CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies
Ugo Testa, Elvira Pelosi, Germana Castelli
Cancers (2019) Vol. 11, Iss. 9, pp. 1358-1358
Open Access | Times Cited: 128
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
Tomohiro Aoki, Ritsuro Suzuki, Yachiyo Kuwatsuka, et al.
Blood (2015) Vol. 125, Iss. 23, pp. 3559-3562
Open Access | Times Cited: 124
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 110
Extramedullary Manifestations of Myeloid Neoplasms
Carla S. Wilson, L. Jeffrey Medeiros
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 2, pp. 219-239
Open Access | Times Cited: 109
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martín‐Martín, Antonio López, María‐Belén Vidriales, et al.
Oncotarget (2015) Vol. 6, Iss. 22, pp. 19204-19216
Open Access | Times Cited: 107
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm
Albrecht Stenzinger, Volker Endris, Nicole Pfarr, et al.
Oncotarget (2014) Vol. 5, Iss. 15, pp. 6404-6413
Open Access | Times Cited: 90
Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy
Wasif Riaz, Ling Zhang, Pedro Horna, et al.
Cancer Control (2014) Vol. 21, Iss. 4, pp. 279-289
Open Access | Times Cited: 81
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan‐Dabaja, Hillard M. Lazarus, Taiga Nishihori, et al.
Biology of Blood and Marrow Transplantation (2013) Vol. 19, Iss. 7, pp. 1006-1012
Open Access | Times Cited: 77
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy
Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares, et al.
Oncotarget (2016) Vol. 7, Iss. 9, pp. 10174-10181
Open Access | Times Cited: 77
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Clinicopathologic Review
Yang Shi, Endi Wang
Archives of Pathology & Laboratory Medicine (2014) Vol. 138, Iss. 4, pp. 564-569
Open Access | Times Cited: 77
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study
Mohamed A. Kharfan‐Dabaja, Monzr M. Al Malki, Uday Deotare, et al.
British Journal of Haematology (2017) Vol. 179, Iss. 5, pp. 781-789
Open Access | Times Cited: 71
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Maria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 729-737
Open Access | Times Cited: 69
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
Uday Deotare, Karen Yee, Lisa W. Le, et al.
American Journal of Hematology (2015) Vol. 91, Iss. 3, pp. 283-286
Open Access | Times Cited: 68
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms
Anouk Emadali, Neda Hoghoughi, Samuel Duley, et al.
Blood (2016) Vol. 127, Iss. 24, pp. 3040-3053
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top